Basic Science Team

We believe that through scientific innovations, we will develop better therapies, improve quality of life, and achieve a cure.
We Believe

We believe that through scientific innovations, we will develop better therapies, improve quality of life, and achieve a cure.

Our laboratory investigators are engaged full-time in cutting-edge basic science research to identify ways to improve the treatment of malignant CNS tumors. The laboratories of full, associate, and secondary Neuro-oncology Program members comprise the basic science team.  

Researchers 

Director, Preston Robert Tisch Brain Tumor Center
Edwin L. Jones, Jr. and Lucille Finch Jones Cancer Research Professor (Focus Group: Immunoconjugates)
Assistant Professor of Radiology (Focus Group: Molecular Studies)
Professor of Neurosurgery, Molecular Genetics and Microbiology, and Medicine (Focus Group: Virotherapy)
Assistant Professor of Pathology (Focus Group: Molecular Studies)
Professor of Neurosurgery (Focus Group: Pre-Clinical Drug Testing)
Associate Professor of Cell Biology and Neurobiology, and Pediatrics (Focus Group: Molecular Studies)
Professor of Pathology (Focus Group: Biobanking)
Dr. Robert H. Wilkins and Gloria Wilkins Professor of Neurosurgery (Focus Group: Active Immunotherapy)
Assistant Professor of Neurosurgery (Focus Group: Active Immunotherapy)
Henry S. Friedman Professor of Neuro-oncology (Focus Group: Molecular Studies)
Gustavo S. Montana Professor of Radiation Oncology (Focus Group: Pre-Clinical Drug Testing)
Associate Professor of Medicine, Associate Research Professor of Molecular Genetics and Microbiology (Focus Group: Molecular Studies)
James B. Duke Professor of Pharmacology and Cancer Biology (Focus Group: Molecular Studies)
Professor of Radiology (Focus Group: Immunoconjugates)
Jonathan Spicehandler, MD, Professor of Neuro-oncology Research (Focus Group: Radio-Immunotherapy)